<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>沈阳药科大学亦弘商学院 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-07T20:25:12+08:00</updated>
  <subtitle>亦弘商学院隶属于沈阳药科大学，实行理事会管理体制下院长负责制的新型学院管理机制。学院以培养医药行业高级管理人才，提升医药领域从业人员的知识、技能为目标。将开展学位教育、高级经理短训、定制教育、网络教育等教学与培训活动。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>新生报到 | 怀匠心，铸匠魂：药品制造管理三期锐意前行（1）</title>
    <updated>2021-01-07T16:56:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/FZCqGPmcHa2-_28IYGToTg</id>
    <link href="https://mp.weixin.qq.com/s/FZCqGPmcHa2-_28IYGToTg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同学说 | 中国式管理智慧：道法术器势</title>
    <updated>2021-01-06T16:21:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/vGPw-_EzBYAE6y-6-ORBtA</id>
    <link href="https://mp.weixin.qq.com/s/vGPw-_EzBYAE6y-6-ORBtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>巡礼2021 | 从研发到生产，从策略到管理，360度赋能</title>
    <updated>2021-01-05T17:40:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/gMH5BtoU_oq2kQdOkXOx9A</id>
    <link href="https://mp.weixin.qq.com/s/gMH5BtoU_oq2kQdOkXOx9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亦弘研究 | OTC管理制度研究干货集锦</title>
    <updated>2021-01-04T17:31:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/jU1o12bp3sYB_meK4bBAvA</id>
    <link href="https://mp.weixin.qq.com/s/jU1o12bp3sYB_meK4bBAvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>分享图片</title>
    <updated>2020-12-31T16:46:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/vjgloOaiw4AFmqA435-DnA</id>
    <link href="https://mp.weixin.qq.com/s/vjgloOaiw4AFmqA435-DnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>告别2020 | 亦弘聚焦 精彩盘点</title>
    <updated>2020-12-31T14:32:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/EFQLzdzra-fwrNtW5IOBSg</id>
    <link href="https://mp.weixin.qq.com/s/EFQLzdzra-fwrNtW5IOBSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亦弘研究 | 关于完善我国非处方药上市路径管理的建议（Ⅱ）</title>
    <updated>2020-12-31T14:32:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/n8Xrj86bI71YHll9rwb3qw</id>
    <link href="https://mp.weixin.qq.com/s/n8Xrj86bI71YHll9rwb3qw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亦弘研究 | 关于完善我国非处方药上市路径管理的建议（Ⅰ）</title>
    <updated>2020-12-30T16:20:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/w6UVnyOmqjVa-y5pJHIIeQ</id>
    <link href="https://mp.weixin.qq.com/s/w6UVnyOmqjVa-y5pJHIIeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亦弘研究 | 我国非处方药上市路径现状调研（Ⅳ）——注册路径</title>
    <updated>2020-12-29T17:49:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/k4nuwlhxlkLJ_ymHINuW6A</id>
    <link href="https://mp.weixin.qq.com/s/k4nuwlhxlkLJ_ymHINuW6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亦弘研究 | 我国非处方药上市路径现状调研(Ⅲ) ——转换路径</title>
    <updated>2020-12-28T17:31:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/IkVxQiu81FmpVdlYn6OPCA</id>
    <link href="https://mp.weixin.qq.com/s/IkVxQiu81FmpVdlYn6OPCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新闻 | 创新生物技术药物临床期间生产场地变更研究课题结题</title>
    <updated>2020-12-28T17:31:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/md5XEx1Al1AZ1751--wJog</id>
    <link href="https://mp.weixin.qq.com/s/md5XEx1Al1AZ1751--wJog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>悦思 | 当代职场酷刑： 99%的人不会开会</title>
    <updated>2020-12-26T19:08:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/nqhsgaUqSpacRLUoNc6KeQ</id>
    <link href="https://mp.weixin.qq.com/s/nqhsgaUqSpacRLUoNc6KeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>